Smoldering Plasma Cell Myeloma Clinical Trials
2 recruiting trials for Smoldering Plasma Cell Myeloma. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT04776395
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering...
This phase II trial studies the effects of iberdomide when given alone or in combination with dexamethasone in treating intermediate or high-risk smoldering multiple myeloma...
Sponsor: Emory UniversityEnrolling: 681 location
RECRUITINGNCT05136807
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
This study examines the quality of life in patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma. Collecting quality of life information from...
Sponsor: M.D. Anderson Cancer CenterEnrolling: 4001 location